Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| type II pneumocyte | 6 studies | 39% ± 13% | |
| CD4-positive, alpha-beta T cell | 6 studies | 39% ± 20% | |
| CD8-positive, alpha-beta T cell | 6 studies | 42% ± 20% | |
| B cell | 4 studies | 22% ± 4% | |
| naive B cell | 4 studies | 20% ± 3% | |
| T follicular helper cell | 3 studies | 30% ± 15% | |
| T cell | 3 studies | 39% ± 21% |
Insufficient scRNA-seq data for expression of CHI3L2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 89% | 645.08 | 583 / 653 | 93% | 44.01 | 563 / 605 |
| breast | 87% | 804.49 | 398 / 459 | 73% | 42.08 | 817 / 1118 |
| lung | 98% | 4150.03 | 565 / 578 | 58% | 12.02 | 670 / 1155 |
| brain | 33% | 661.72 | 864 / 2642 | 83% | 131.06 | 583 / 705 |
| skin | 60% | 492.39 | 1079 / 1809 | 45% | 7.49 | 213 / 472 |
| bladder | 76% | 371.38 | 16 / 21 | 28% | 5.92 | 142 / 504 |
| spleen | 98% | 1317.43 | 237 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 80.35 | 28 / 29 |
| peripheral blood | 80% | 2900.17 | 742 / 929 | 0% | 0 | 0 / 0 |
| prostate | 45% | 476.07 | 110 / 245 | 33% | 7.75 | 168 / 502 |
| adipose | 76% | 955.75 | 919 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 29% | 191.60 | 26 / 89 | 38% | 6.56 | 343 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 60% | 8.03 | 27 / 45 |
| blood vessel | 54% | 749.71 | 726 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 30% | 210.24 | 427 / 1445 | 21% | 2.63 | 38 / 183 |
| heart | 50% | 584.36 | 432 / 861 | 0% | 0 | 0 / 0 |
| intestine | 25% | 224.53 | 246 / 966 | 12% | 1.78 | 61 / 527 |
| stomach | 21% | 279.42 | 75 / 359 | 16% | 2.24 | 45 / 286 |
| uterus | 4% | 10.31 | 6 / 170 | 31% | 6.68 | 141 / 459 |
| pancreas | 1% | 1.18 | 2 / 328 | 31% | 3.28 | 55 / 178 |
| adrenal gland | 26% | 162.11 | 66 / 258 | 4% | 0.85 | 9 / 230 |
| ovary | 12% | 79.64 | 21 / 180 | 13% | 2.99 | 56 / 430 |
| muscle | 10% | 45.25 | 84 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 9% | 1.15 | 7 / 80 |
| liver | 0% | 0 | 0 / 226 | 5% | 0.65 | 19 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005975 | Biological process | carbohydrate metabolic process |
| GO_0006032 | Biological process | chitin catabolic process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0004568 | Molecular function | chitinase activity |
| GO_0008061 | Molecular function | chitin binding |
| Gene name | CHI3L2 |
| Protein name | Chitinase-3-like protein 2 (Chondrocyte protein 39) (YKL-39) Chitinase 3 like 2 |
| Synonyms | |
| Description | FUNCTION: Lectin that binds chitooligosaccharides and other glycans with high affinity, but not heparin. Has no chitinase activity. . |
| Accessions | H0YEJ1 E9PP75 ENST00000474304.6 ENST00000528451.5 E9PIX1 Q15782 ENST00000472825.2 ENST00000497220.5 ENST00000369748.9 [Q15782-4] E9PII8 H0YE91 ENST00000466741.5 [Q15782-5] ENST00000486561.6 E9PRL9 ENST00000467038.6 E9PR52 E9PPX4 ENST00000477185.6 ENST00000445067.6 [Q15782-4] ENST00000533831.6 ENST00000497587.6 ENST00000369744.6 [Q15782-6] H0YD88 ENST00000524472.5 [Q15782-5] |
